GB201414181D0 - Method - Google Patents

Method

Info

Publication number
GB201414181D0
GB201414181D0 GBGB1414181.6A GB201414181A GB201414181D0 GB 201414181 D0 GB201414181 D0 GB 201414181D0 GB 201414181 A GB201414181 A GB 201414181A GB 201414181 D0 GB201414181 D0 GB 201414181D0
Authority
GB
United Kingdom
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1414181.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCL Business Ltd
Original Assignee
UCL Business Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCL Business Ltd filed Critical UCL Business Ltd
Priority to GBGB1414181.6A priority Critical patent/GB201414181D0/en
Publication of GB201414181D0 publication Critical patent/GB201414181D0/en
Priority to PCT/GB2015/052318 priority patent/WO2016024104A1/en
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/16—Ophthalmology

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GBGB1414181.6A 2014-08-11 2014-08-11 Method Ceased GB201414181D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1414181.6A GB201414181D0 (en) 2014-08-11 2014-08-11 Method
PCT/GB2015/052318 WO2016024104A1 (en) 2014-08-11 2015-08-11 Method for detecting inflammatory cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1414181.6A GB201414181D0 (en) 2014-08-11 2014-08-11 Method

Publications (1)

Publication Number Publication Date
GB201414181D0 true GB201414181D0 (en) 2014-09-24

Family

ID=51629584

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1414181.6A Ceased GB201414181D0 (en) 2014-08-11 2014-08-11 Method

Country Status (2)

Country Link
GB (1) GB201414181D0 (en)
WO (1) WO2016024104A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114304062B (en) * 2020-09-30 2022-12-06 北京市眼科研究所 Construction method and application of autoimmune retinopathy animal model

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100034749A1 (en) * 2006-07-10 2010-02-11 Medigene Ag Use of a Cationic Collodal Preparation for the Diagnosis and Treatment of Ocular Diseases
US8771741B2 (en) * 2009-01-23 2014-07-08 The Penn State Research Foundation In vivo photodynamic therapy of cancer via a near infrared agent encapsulated in calcium phosphate nanoparticles
WO2014002100A1 (en) * 2012-06-28 2014-01-03 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Compositions comprising near-infrared fluorescent particles and uses thereof for imaging activated immune cells in the cns

Also Published As

Publication number Publication date
WO2016024104A1 (en) 2016-02-18

Similar Documents

Publication Publication Date Title
GB201417712D0 (en) Method
GB201406151D0 (en) Method
GB201418159D0 (en) Method
GB201409558D0 (en) Method
GB201406155D0 (en) Method
GB201408119D0 (en) Method
GB201414496D0 (en) Method
GB201417042D0 (en) Method
GB201413240D0 (en) Method
GB201403470D0 (en) Method
GB201410022D0 (en) Method
GB201410101D0 (en) Method
GB201416675D0 (en) Method
GB201412802D0 (en) Method
GB201411500D0 (en) Method
GB201409128D0 (en) Method
GB201416849D0 (en) Method
GB201412736D0 (en) Method
GB201412226D0 (en) Method
GB201409234D0 (en) Method
GB201409101D0 (en) Method
GB201414181D0 (en) Method
GB201413929D0 (en) Method
GB201413612D0 (en) Method
GB201408649D0 (en) Method

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)